Skip to main content
ACADIA PHARMACEUTICALS INC logo

ACADIA PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · ACAD ISIN · US0042251084 LEI · 529900O3044NO0PEA039 US Manufacturing
Filings indexed 1,013 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country US United States of America
Listing US ACAD

About ACADIA PHARMACEUTICALS INC

https://acadia.com/

ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.

Recent filings

Filing Released Lang Actions
8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)
Regulatory Filings
2026-05-06 English
4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
Director's Dealing
2026-03-27 English
4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
Director's Dealing
2026-03-27 English
4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
Director's Dealing
2026-03-27 English
4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
Director's Dealing
2026-03-27 English
4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
Director's Dealing
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.